 |
Michael Bilirakis (ed.). Witnesses: Jane L. Delgado, Pres. & CEO, Nat. Alliance for Hispanic Health; Bruce L. Downey, Chmn., & CEO, Barr Laboratories, on Behalf of the Generic Pharmaceutical Assoc.; Thomas Geiser, General Counsel, & Robert Seidman, V.P., Pharmacy, Wellpoint Health Networks; Gregory J. Glover, Ropes & Gray, on Behalf of Pharmaceutical Researchers & Manufacturers of America; John D. Golenski, Exec. Dir., RX Health Value; Richard F. Kinghamn, Covington & Burling; & Janet Woodcock, Dir., Center for Drug Evaluation & Research, Food & Drug Admin. (FDA).
|
|
|
